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Epididymalleiomyosarcomaisveryuncommon.Only16caseshavebeenreportedintheliterature.Therehasneverbeenareported
case of a patient with an African origin with this tumor. We report the medical history of a 70-year-old man who presented an
enormous mass located in his epididymis. A tricut biopsy was performed which allowed histological conﬁrmation of epididymal
leiomyosarcoma after which the patient underwent excision of the mass. The patient died after the ﬁrst round of chemotherapy.
1.Introduction
Leiomyosarcoma is a tumor that can arise from any organ
that contains smooth muscles. Its development in the epidi-
d y m u si sr a r e .
Early diagnostics of this tumor have proven to be of good
prognosis as many studies have showed.
Surgical resection of the tumor associated with adjuvant
chemotherapy seems eﬃcient in its treatment.
Wereportacaseofa70-year-oldmanwhowasdiagnosed
of leiomyosarcoma of the epididymis treated by excision of
the mass followed by the 1st round of chemotherapy before
his death.
2. Case Presentation
A 70-year-old Moroccan male with no medical history,
presented with a scrotal mass located in the left testicle
and along the spermatic cord which increased in volume
gradually. Medical examination showed a patient with
an altered general state and an ulcerovegetant mass with
its largest diameter measuring 25cm associated with an
enlarged ﬁstulised inguinal lymph node (Figure 1).
Thedosageoftumormarkers(HCG,alphafoetalprotein,
and PA) was negative.
Atricutbiopsywasrealizedfollowedbyhistologicalstudy
of the masss which conﬁrmed an epididymal leiomyosar-
coma (Figure 2).
The patient underwent excision of the mass followed by
the ﬁrst round of chemotherapy, and he passed away after a
month.
3. Discussion
Leiomyosarcomaofparatesticulartissuesisveryuncommon.
It arises from smooth muscles which form the muscles of
the scrotal sac, the seminiferous tubules, and the vascular
tissues of the spermatic cord(). Its principal location is in the
testicular walls and the spermatic cord [1].
Epididymal leiomyosarcoma occurs in men with ages
between 50 and 80 years. It may also occur in children as
there has been a reported case in a 6-year-old child [2].
Certain predisposing factors have been described in
the literature leading to testicular leiomyosarcoma such as
exposure to large doses of anabolising steroids [3], chronic
inﬂammation [4], or past radiotherapy.
There are no reported predisposing factors leading to
epididymal leiomyosarcoma with respect to its prognosis in
the literature.2 Case Reports in Urology
Figure 1: An ulcerovegetant mass with an enlarged ﬁstulised
inguinal lymph node.
Figure 2: Pathology reports atypic (HES ×400).
It is diﬃcult to deﬁne aggressive forms of this tumor
due to its relatively rare occurrence; however, its aggressivity
seems less important with respect to its location, as there
has only been a single case reported of recurrence and of
metastasis. The lack of a universal histological classiﬁcation
contributes to the diﬃculty in determining histological
characters that inﬂuence the prognosis of this tumor.
The only character described frequently is the mitotic
index which is often elevated. Nevertheless, it seems not
to help predict the agressivity of the tumor as well as its
prognosis as it is not strictly related to the recurrence of the
tumor nor the occurrence of metastasis [5].
Histologicalstudiesofthemassbiopsiedshowedelevated
mitotic index.
Immunohistochemical studies showed diﬀerentiated
smooth muscle cells that tested positive for actin, desmin,
and caldesmon. The diagnosis of leiomyosarcoma was made
upon these ﬁndings.
Most authors prefer treatment by orchidectomy only [6].
Anadjuvanttherapywasrealizedintwocases:chemotherapy
adjuvant in the ﬁrst case (due to elevated mitotic index) [7]
and radiochemotherapy in the second case [8].
Some authors reported that an adjuvant therapy may
be performed in cases where there exist elevated mitotic
index. However, it is diﬃcult to determine the beneﬁts of this
complementary treatment as few cases have been reported in
the literature [9].
4. Conclusion
The epididymis represents a rare location for leiomyosar-
coma although its histological characteristics are the same as
that found in other organs.
There is no morphological criteria that determine its
prognosis (relating to its aggressivity) as well as an anatomo-
pathological classiﬁcation that will help to grade this tumor.
In these present times, information from the literature
shows that radical orchidectomy seems to be the underlying
treatment for this tumor. There is no proven eﬃcacy for any
adjuvant therapy.
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